Determinants of the Use of Coronary Angiography and Revascularization after Thrombolysis for Acute Myocardial Infarction

Physicians routinely make difficult decisions about which patients with acute myocardial infarction should undergo angiography, which to refer for revascularization, and which type of revascularization procedure to use. 1 Although clinical trials have evaluated the effect of different strategies on...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 335; no. 16; pp. 1198 - 1205
Main Authors Pilote, Louise, Miller, Dave P, Califf, Robert M, Rao, J. Sunil, Weaver, W. Douglas, Topol, Eric J
Format Journal Article
LanguageEnglish
Published Boston, MA Massachusetts Medical Society 17.10.1996
Subjects
Age Factors
Aged
Aged, 80 and over
Biological and medical sciences
Cardiology. Vascular system
Clinical medicine
Confidence intervals
Coronary Angiography - statistics & numerical data
Coronary Angiography - utilization
Coronary heart disease
Heart
Heart attacks
Humans
Logistic Models
Logistics
Medical imaging
Medical sciences
Myocardial Infarction - diagnostic imaging
Myocardial Infarction - drug therapy
Myocardial Infarction - surgery
Myocardial Revascularization - statistics & numerical data
Myocardial Revascularization - utilization
Physicians
Regression Analysis
Studies
Thrombolytic Therapy
Variables
United States > US
Human
Prognosis
Radiodiagnosis
Infarct
Acute
Cardiovascular disease
Coronary arteriography
Coronary heart disease
Myocardial disease
Cohort study
Myocardium
Strategy
Revascularization
Online AccessGet full text

Cover

More Information
Summary:Physicians routinely make difficult decisions about which patients with acute myocardial infarction should undergo angiography, which to refer for revascularization, and which type of revascularization procedure to use. 1 Although clinical trials have evaluated the effect of different strategies on outcome, the behavior and practice of physicians have rarely been studied in large trials. 2-7 In most practice guidelines, clinical risk factors are used to identify candidates appropriate for certain treatments. 8-10 Whether in clinical practice these characteristics identify patients suitable for the treatments remains unknown. The first prospective Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries trial (GUSTO-1) . . .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM199610173351606